NC
MRNS

Nexthera Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Nexthera Capital’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-231,332
Closed -$7.55M – 54
2017
Q4 		$7.55M Buy
231,332
+81,332
+54% +$2.19M 1.39% 23
2017
Q3 		$3.52M Buy
150,000
+25,000
+20% +$280K 0.91% 29
2017
Q2 		$685K Sell
125,000
-75,000
-38% -$405K 0.3% 35
2017
Q1 		$1.42M Buy
+200,000
New +$1.07M 0.72% 25
2016
Q1 		– Sell
-6,250
Closed -$191K – 45
2015
Q4 		$191K Buy
+6,250
New +$183K 0.27% 38

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nexthera Capital's MRNS Position: Q1 2018 in Review

Nexthera Capital sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2018, closing a stake of 231,332 shares — an estimated $7.55M sold.

Nexthera Capital first reported a position in MRNS in Q4 2015 and held it in 5 quarters. The position peaked at $7.55M in Q4 2017. 60 funds tracked by Wall St. Rank hold MRNS as of Q1 2018.

  • Nexthera Capital reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2018 after selling out during the quarter.
  • Nexthera Capital sold 231,332 Marinus Pharmaceuticals, Inc shares in Q1 2018, an estimated $7.55M.
  • Nexthera Capital first reported a position in Marinus Pharmaceuticals, Inc in Q4 2015 and held it in 5 quarters.
  • Nexthera Capital's Marinus Pharmaceuticals, Inc position peaked at $7.55M in Q4 2017.
  • 60 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2018.

Based on Nexthera Capital's 13F filing for Q1 2018, filed 15 May 2018.